Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 124

1.

Early miR-155 upregulation contributes to neuroinflammation in Alzheimer's disease triple transgenic mouse model.

Guedes JR, Custódia CM, Silva RJ, de Almeida LP, Pedroso de Lima MC, Cardoso AL.

Hum Mol Genet. 2014 Dec 1;23(23):6286-301. doi: 10.1093/hmg/ddu348. Epub 2014 Jul 2.

2.

RAGE-dependent signaling in microglia contributes to neuroinflammation, Abeta accumulation, and impaired learning/memory in a mouse model of Alzheimer's disease.

Fang F, Lue LF, Yan S, Xu H, Luddy JS, Chen D, Walker DG, Stern DM, Yan S, Schmidt AM, Chen JX, Yan SS.

FASEB J. 2010 Apr;24(4):1043-55. doi: 10.1096/fj.09-139634. Epub 2009 Nov 11.

3.

Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease.

Jin JJ, Kim HD, Maxwell JA, Li L, Fukuchi K.

J Neuroinflammation. 2008 May 29;5:23. doi: 10.1186/1742-2094-5-23.

4.

Human APOE4 increases microglia reactivity at Aβ plaques in a mouse model of Aβ deposition.

Rodriguez GA, Tai LM, LaDu MJ, Rebeck GW.

J Neuroinflammation. 2014 Jun 19;11:111. doi: 10.1186/1742-2094-11-111.

5.

Quantitative proteomics reveals that PEA15 regulates astroglial Aβ phagocytosis in an Alzheimer's disease mouse model.

Lv J, Ma S, Zhang X, Zheng L, Ma Y, Zhao X, Lai W, Shen H, Wang Q, Ji J.

J Proteomics. 2014 Oct 14;110:45-58. doi: 10.1016/j.jprot.2014.07.028. Epub 2014 Aug 7.

PMID:
25108202
6.

Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.

Edwards MM, Rodríguez JJ, Gutierrez-Lanza R, Yates J, Verkhratsky A, Lutty GA.

Exp Eye Res. 2014 Oct;127:252-60. doi: 10.1016/j.exer.2014.08.006. Epub 2014 Aug 19.

7.

Chronic neuron-specific tumor necrosis factor-alpha expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice.

Janelsins MC, Mastrangelo MA, Park KM, Sudol KL, Narrow WC, Oddo S, LaFerla FM, Callahan LM, Federoff HJ, Bowers WJ.

Am J Pathol. 2008 Dec;173(6):1768-82. doi: 10.2353/ajpath.2008.080528. Epub 2008 Oct 30.

8.

The contribution of activated astrocytes to Aβ production: implications for Alzheimer's disease pathogenesis.

Zhao J, O'Connor T, Vassar R.

J Neuroinflammation. 2011 Nov 2;8:150. doi: 10.1186/1742-2094-8-150.

9.

Isoglutaminyl cyclase contributes to CCL2-driven neuroinflammation in Alzheimer's disease.

Hartlage-Rübsamen M, Waniek A, Meissner J, Morawski M, Schilling S, Jäger C, Kleinschmidt M, Cynis H, Kehlen A, Arendt T, Demuth HU, Rossner S.

Acta Neuropathol. 2015 Apr;129(4):565-83. doi: 10.1007/s00401-015-1395-2. Epub 2015 Feb 11.

10.

The CCAAT/enhancer binding protein (C/EBP) δ is differently regulated by fibrillar and oligomeric forms of the Alzheimer amyloid-β peptide.

Ramberg V, Tracy LM, Samuelsson M, Nilsson LN, Iverfeldt K.

J Neuroinflammation. 2011 Apr 14;8:34. doi: 10.1186/1742-2094-8-34.

11.

Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.

Magga J, Puli L, Pihlaja R, Kanninen K, Neulamaa S, Malm T, Härtig W, Grosche J, Goldsteins G, Tanila H, Koistinaho J, Koistinaho M.

J Neuroinflammation. 2010 Dec 7;7:90. doi: 10.1186/1742-2094-7-90.

12.

Tenascin-C deficiency ameliorates Alzheimer's disease-related pathology in mice.

Xie K, Liu Y, Hao W, Walter S, Penke B, Hartmann T, Schachner M, Fassbender K.

Neurobiol Aging. 2013 Oct;34(10):2389-98. doi: 10.1016/j.neurobiolaging.2013.04.013. Epub 2013 May 11.

PMID:
23673309
13.

Upregulation of miR-181 decreases c-Fos and SIRT-1 in the hippocampus of 3xTg-AD mice.

Rodriguez-Ortiz CJ, Baglietto-Vargas D, Martinez-Coria H, LaFerla FM, Kitazawa M.

J Alzheimers Dis. 2014;42(4):1229-38. doi: 10.3233/JAD-140204.

PMID:
25024332
14.

Resting microglia react to Aβ42 fibrils but do not detect oligomers or oligomer-induced neuronal damage.

Ferrera D, Mazzaro N, Canale C, Gasparini L.

Neurobiol Aging. 2014 Nov;35(11):2444-57. doi: 10.1016/j.neurobiolaging.2014.05.023. Epub 2014 May 29.

PMID:
24973120
15.

Microglia, neuroinflammation, and beta-amyloid protein in Alzheimer's disease.

Cai Z, Hussain MD, Yan LJ.

Int J Neurosci. 2014 May;124(5):307-21. doi: 10.3109/00207454.2013.833510. Epub 2013 Sep 12. Review.

PMID:
23930978
16.

Amyloid β and Tau Alzheimer's disease related pathology is reduced by Toll-like receptor 9 stimulation.

Scholtzova H, Chianchiano P, Pan J, Sun Y, Goñi F, Mehta PD, Wisniewski T.

Acta Neuropathol Commun. 2014 Sep 2;2:101. doi: 10.1186/s40478-014-0101-2.

17.

Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms.

Giuliani D, Ottani A, Zaffe D, Galantucci M, Strinati F, Lodi R, Guarini S.

Neurobiol Learn Mem. 2013 Sep;104:82-91. doi: 10.1016/j.nlm.2013.05.006. Epub 2013 May 31.

PMID:
23726868
18.

Restoration of lipoxin A4 signaling reduces Alzheimer's disease-like pathology in the 3xTg-AD mouse model.

Dunn HC, Ager RR, Baglietto-Vargas D, Cheng D, Kitazawa M, Cribbs DH, Medeiros R.

J Alzheimers Dis. 2015;43(3):893-903. doi: 10.3233/JAD-141335.

19.

Microglial derived tumor necrosis factor-α drives Alzheimer's disease-related neuronal cell cycle events.

Bhaskar K, Maphis N, Xu G, Varvel NH, Kokiko-Cochran ON, Weick JP, Staugaitis SM, Cardona A, Ransohoff RM, Herrup K, Lamb BT.

Neurobiol Dis. 2014 Feb;62:273-85. doi: 10.1016/j.nbd.2013.10.007. Epub 2013 Oct 17.

20.

Chronic IL-1β-mediated neuroinflammation mitigates amyloid pathology in a mouse model of Alzheimer's disease without inducing overt neurodegeneration.

Matousek SB, Ghosh S, Shaftel SS, Kyrkanides S, Olschowka JA, O'Banion MK.

J Neuroimmune Pharmacol. 2012 Mar;7(1):156-64. doi: 10.1007/s11481-011-9331-2. Epub 2011 Dec 16.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk